Form 3: OACC CFO George Martinez reports no ownership

Rhea-AI Filing Summary

Oaktree Acquisition Corp. III Life Sciences (OACC) reported an insider ownership update. The company’s Chief Financial Officer, George Martinez, filed a Form 3 initial statement under Section 16, effective 10/29/2025. The filing states that no securities are beneficially owned. The submission includes Exhibit 24 (Power of Attorney) and is filed by one reporting person.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Martinez George Arthur

(Last) (First) (Middle)

333 SOUTH GRAND AVENUE, 28TH FLOOR

(Street)

LOS ANGELES CA 90071

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/29/2025

3. Issuer Name and Ticker or Trading Symbol
Oaktree Acquisition Corp. III Life Sciences [ OACC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ George Martinez	10/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OACC disclose in this Form 3?

The CFO, George Martinez, filed an initial statement of beneficial ownership indicating no securities are beneficially owned.

Who is the reporting person for OACC (OACC) in this filing?

The reporting person is George Martinez, serving as Chief Financial Officer.

What is the event date on the OACC Form 3?

The event date is 10/29/2025.

Is this a joint filing?

No. It is filed by one reporting person.

Does the OACC CFO own any securities according to the filing?

No. The filing states no securities are beneficially owned.

What exhibit accompanies the Form 3?

The filing includes Exhibit 24 - Power of Attorney.

What is the issuer’s name and ticker?

The issuer is Oaktree Acquisition Corp. III Life Sciences with ticker OACC.